Aytu BioPharma Inc (AYTU)
1.508
+0.02
(+1.22%)
USD |
NASDAQ |
Nov 21, 16:00
1.48
-0.03
(-1.87%)
After-Hours: 20:00
Aytu BioPharma Debt to Equity Ratio: 0.5551 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.5551 |
| June 30, 2024 | 0.5459 |
| March 31, 2024 | 0.5426 |
| December 31, 2023 | 0.4883 |
| September 30, 2023 | 0.5011 |
| June 30, 2023 | 0.4157 |
| March 31, 2023 | 0.6134 |
| December 31, 2022 | 0.4813 |
| September 30, 2022 | 0.4187 |
| June 30, 2022 | 0.4105 |
| March 31, 2022 | 0.2887 |
| December 31, 2021 | 0.2244 |
| September 30, 2021 | 0.19 |
| June 30, 2021 | 0.1801 |
| March 31, 2021 | 0.161 |
| December 31, 2020 | 0.0067 |
| September 30, 2020 | 0.0174 |
| June 30, 2020 | 0.0103 |
| March 31, 2020 | 0.0532 |
| December 31, 2019 | 0.0154 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.3202 |
| December 31, 2018 | 0.2531 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.0006 |
| December 31, 2015 | 0.3225 |
| September 30, 2015 | 0.3599 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| February 28, 2015 | -0.6896 |
| November 30, 2014 | -0.7256 |
| August 31, 2014 | -0.6887 |
| May 31, 2014 | -0.7914 |
| February 28, 2014 | -0.7646 |
| November 30, 2013 | -0.8315 |
| August 31, 2013 | -0.8977 |
| May 31, 2013 | -0.9069 |
| February 28, 2013 | -0.8787 |
| November 30, 2012 | 0.00 |
| August 31, 2012 | -0.9761 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0067
Minimum
Dec 2020
0.6134
Maximum
Mar 2023
0.306
Average
0.3496
Median
Debt to Equity Ratio Benchmarks
| enVVeno Medical Corp | -- |
| Bristol-Myers Squibb Co | 2.902 |
| Telesis Bio Inc | 0.5307 |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.9382 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 115.83M |
| Total Liabilities (Quarterly) | 86.00M |
| Shareholders Equity (Quarterly) | 29.83M |
| Current Ratio | 0.9916 |
| Net Debt Paydown Yield | -0.27% |